with Dr. Borja De Lacy
The COLOR II trial is designed to obtain the strongest level of evidence regarding minimal invasive surgery for rectal cancer. It is a randomized clinical trial that compares open and laparoscopic surgery for rectal cancer involving centers in Europe, Canada and South Korea.
A similar study compares Robotic vs laparoscopic rectal cancer resection (the ROLARR trial). Short-term outcomes are available for both of them. In this lecture, Borja de Lacy explains the study designs and their results.
Share it with your network and help spread clinical knowledge.
